Sort   by:  
 Page size 
UnknownTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618 | biostudies-literature
UnknownUtility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.
Not available
S-EPMC7202045 | biostudies-literature
UnknownClinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration.
Not available
S-EPMC6988137 | biostudies-literature
UnknownNonlinear Z-score modeling for improved detection of cognitive abnormality.
Not available
S-EPMC6911910 | biostudies-literature
UnknownEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219 | biostudies-literature
UnknownAssessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.
Not available
S-EPMC6842665 | biostudies-literature
UnknownRisk of COVID-19 after natural infection or vaccination.
Not available
S-EPMC10518569 | biostudies-literature
UnknownIndividualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration.
Not available
S-EPMC6938544 | biostudies-literature
UnknownTwo Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Not available
S-EPMC10794000 | biostudies-literature
UnknownGlobal, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Not available
S-EPMC4165626 | biostudies-literature
Sort   by:  
 Page size